On-demand strategy as an alternative to conventionally scheduled post-transplant immunoadsorptions after ABO-incompatible kidney transplantation

Abstract

Using this on-demand strategy, our data reveal that a titer-dependent protocol reduces costs at no additional risk for the patient.